Review of Melatonin and Results of Students Survey
DOI:
https://doi.org/10.17140/PMHCOJ-8-147Keywords:
Melatonin, Dietary supplement, Insomnia, Weight gain, Cancer, LightAbstract
PurposeThe objective of the survey is to evaluate the knowledge and opinion of Howard University College of Pharmacy first-year pro-fessional pharmacy students regarding the use of the sleep medication melatonin.
Methods
A survey questionnaire comprising 20 questions on melatonin was developed and response obtained from 42 students. Demo-graphic data and responses were gathered and evaluated. Descriptive statistics were used to analyze the responses.
Results
Most of the respondents had adequate knowledge about melatonin ranging from 54.8 to 92.6%. There was no statistical differ-ence when responses were analyzed based on the gender of the survey participants. To specific questions whether melatonin is associated with weight gain, can help with signs and symptoms of cancer, recommend sleep hygiene instead of melatonin, and whether melatonin is addictive, the majority (57.1%, 42.9%, 64.3% and 69.0%, respectively) provided the wrong responses.
Conclusion
More than half of the respondents had good levels of knowledge and opinion about melatonin, with the highest being 92.6% to a specific question on the use of melatonin. The students were only deficient in areas of melatonin being associated with weight gain, melatonin helping with signs and symptoms of cancer, recommending sleep hygiene, and melatonin causing addiction. There are significant differences between the age groups and whether those who worth healthcare area, or not in their response to some of the survey questions.
References
Hume AL. Melatonin. Naturalproducts. 2019; 25(5): 16.
Waghel RC, Wilson JA. Melatonin: Considerations for Use in Pa-tients with Sleep Disorders. PharmTimes. https://www.pharma-cytimes.com/view/melatonin-considerations-for-use-in-patients-with-sleep-disorders. 2020; 1(1). Accessed March 17, 2022.
Masters A, Pandi-Perumal SR, Seixas A, Girardin J-L, McFar-lane SI. Melatonin, the hormone of darkness: From sleep promo-tion to ebola treatment. Brain Disord Ther. 2015; 4: 1000151. doi: 10.4172/2168-975X.1000151
Liira J, Verbeek JH, Costa J, et al. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. Cochrane Submit your article to this journal | https://openventio.org/submit-manuscript/ Original Research | Volume 8 | Number 1| Hailemeskel B, et al Database Syst Rev. 2014; (8): CD009776. doi: 10.1002/14651858
Walecka-Kapica E, Klupińska G, Chojnacki J, Tomaszews-ka-Warda K, Błońska A, Chojnacki C. The effect of melatonin supplementation on the quality of sleep and weigh status of menopausal women. Prz Menopauzalny. 2014; 13(6): 334-338. doi: 10.5114/pm.2014.47986
Jaiswal SJ, Quer G, Galarnyk M, Steinhubl SR, Topol EJ, Owens RL. Association of sleep duration and variability with Body Mass Index. JAMA Intern Med. 2020; 180(12): 1694-1696. doi: 10.1001/ jamainternmed.2020.2834
Li Y, Li S, Zou Y, et al. Melatonin for the prevention and treatment of cancer. Oncotarget. 2017; 8(24): 39896-39921. doi: 10.18632/oncotarget.16379
Smith S, Vickery B, Kouzi M, Patel K. Melatonin use in an in-patient academic medical center: Factors affecting provider docu-mentation of patients’ sleep quality. J Am Pharm Assoc. 2019; 59(4): 533-538. doi: 10.1016/j.japh.2019.03.010
Al-Arifi MN. Assessment of knowledge, attitudes, and factors influencing students’ selection of generic medicines. Front Public Health. 2021; 8: 767128. doi: 10.3389/fpubh.2021.767128
Osemene KP, Aflobi MO. An evaluation of the knowledge of pharmacy students on pharmacovigilance activities in Nigeria. BMC Res Notes. 2017; 10: 273. doi: 10.1186/s13104-017-2586-9
Gilligan AM, Warholak TL, Murphy JE, Hines LE, Malone DC. Pharmacy students’ retentions of knowledge of drug-drug interac-tions. Am J Pharm Educ. 2011; 75(6): 110. doi: 10.5688/ajpe756110
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Palliative Medicine and Hospice Care (PMHC) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.